Water treatment byproducts linked to thousands of bladder cancers in Europe

An image showing tap water

Call for countries to do more to drive down levels of trihalomethanes produced during disinfection

Around 5% of all cases of bladder cancer in Europe can be attributed to exposure to trihalomethanes (THMs) that form in drinking water, according to a new study. The team conclude that countries with higher than average THMs should take action to cut levels of disinfectant byproducts in tap water. Chlorine is the most widely used disinfectant for drinking water. However, when free chlorine reacts with organic compounds in water it can generate disinfection byproducts including THMs, which have been associated with bladder cancer.

To continue reading this article

You need to sign in or choose one of these options

Subscribe

£36 annual | Pay monthly | Pass
Subscribers get unlimited access to Chemistry World. No more paywalls. Plus your subscription will help fund the charitable work of the Royal Society of Chemistry, supporting chemists worldwide.

Register

Free
You'll be able to read more articles each month before you see another paywall. Perfect if you're a light user or want to read more before deciding to subscribe. It takes less than a minute and it's completely free.

Membership

Included as benefit
Members of the Royal Society of Chemistry have unlimited access to Chemistry World as a benefit of membership. Just sign in with your usual membership credentials. Not a member? Find out how to join.